Skip to main content
Kavera

Post-Concussion Syndrome

Post-concussion syndrome (PCS) is the persistence of concussion-related symptoms — commonly headache, dizziness, sleep disruption, and cognitive complaints in attention, processing speed, and working memory — beyond the typical recovery window, generally defined as symptoms lasting more than 3 months. It affects roughly 10–30% of mild TBI patients and requires structured, repeated monitoring rather than a single follow-up visit.

Prevalence and Mechanism

Most patients recover from a concussion within about 2 weeks (adults) to 4 weeks (children and adolescents), but a meaningful minority — commonly cited in the range of 10–30% — go on to develop persistent post-concussive symptoms. PCS is not a single pathophysiological entity. It reflects a heterogeneous mix of contributors: neurometabolic disruption (glutamate excitotoxicity, altered cerebral glucose metabolism, axonal microstructural injury), and non-structural drivers including vestibulo-ocular dysfunction, cervicogenic factors, comorbid or emergent mood/anxiety symptoms, and expectation or secondary-gain effects. Known risk factors for a protracted course include a history of prior concussion, pre-existing migraine, pre-existing anxiety or depression, and female sex. Because the mechanism is mixed, effective management depends on identifying which symptom domain — vestibular, cervical, cognitive, or affective — is driving a given patient's presentation, which in turn depends on having comparable data over time rather than a single snapshot. See StatPearls on Postconcussive Syndrome and PMC: Complexity of PCS assessment and management for background.

Cognitive and Clinical Impact

Cognitive complaints — slowed processing speed, reduced sustained attention, and working-memory lapses — are among the most common and most functionally disruptive PCS symptoms, alongside headache and sleep disturbance. Subjective symptom report alone tends to underestimate functional impairment: patients frequently plateau on self-reported severity scales while objective cognitive testing continues to show measurable deficits, or the reverse. Left untracked, unresolved cognitive symptoms drive three predictable problems in practice: prolonged work or school disability, misattribution of cognitive complaints to an untreated comorbid mood or anxiety disorder rather than the injury itself, and premature return-to-play or return-to-work clearance that raises re-injury risk. Sleep dysfunction and headache frequently co-travel with cognitive complaints in this population and should be tracked alongside cognition rather than as isolated issues — see Sleep Dysfunction After Concussion and Headache After Concussion.

Monitoring Approach and Cadence

A defensible PCS monitoring plan generally follows this arc:

  • Baseline (if available): A brief in-clinic cognitive screen or prior baseline-testing data at the initial post-injury visit.
  • Weeks 1–2: Reassess symptoms and cognition; most patients on a normal trajectory show improvement here.
  • Weeks 2–4, recurring every 2–4 weeks: Continue symptom and cognitive tracking until resolution or a clear plateau.
  • Beyond 4 weeks without improvement (adults): Escalate to formal neuropsychological evaluation and multidisciplinary rehabilitation referral — see When to Refer for Neuropsych Testing.
  • Beyond 3 months (PCS threshold): Move to a defined PCS management pathway with quarterly reassessment, tracking each contributing symptom domain separately.

This cadence is where between-visit monitoring matters most: PCS by definition plays out over months, but most practices only see the patient episodically. Structured assessment delivered between visits closes that gap and gives the clinician a trend line instead of a series of disconnected snapshots. It also generates a documentation trail that supports Remote Therapeutic Monitoring billing when the monitoring is device- or app-delivered and clinically reviewed.

Relevant Instruments and Modules

PCS assessment should combine a symptom-severity scale, mood/anxiety screening, sleep screening, and cognitive-domain testing:

These map onto the cognitive-domain pages Attention, Processing Speed, and Executive Function, and into Kavera's Concussion module, which bundles this instrument set into a single between-visit battery. Related protocol decisions — clearing an athlete, a student, or a return-to-work timeline — are covered in Return to Play Decision Criteria, Return to Learn, and Return to Work After Concussion. For the overall expected trajectory, see Post-Concussion Recovery Timeline.

How Kavera Handles This

Persistent symptoms are where the Kavera concussion protocol earns its keep: weekly PCSS check-ins, brain training for attention, mood and sleep screens, cognitive tests on your cadence, monthly telehealth, and re-evaluation against the first-visit baseline. Every month of that is documented for RTM and testing codes. Self-Serve practices run this with their own staff. On Managed, Juliet Mott's team runs it and bills it under your credentials.

FAQ

Common questions

How long do symptoms need to persist before a diagnosis of post-concussion syndrome is appropriate?
PCS is generally defined by persistence of concussion symptoms beyond the typical recovery window, commonly cited as more than 3 months post-injury, though clinical judgment and symptom trajectory matter more than a single cutoff date.
Which cognitive domains are most commonly affected in PCS?
Processing speed, sustained attention, and working memory are the domains most frequently implicated, which is why brief, repeatable tests targeting those domains are more practically useful for longitudinal tracking than a single comprehensive neuropsych battery early on.
When should a PCS patient be referred for formal neuropsychological testing?
Referral is generally appropriate when cognitive or symptom complaints have not meaningfully improved by around 4 weeks post-injury, or when the clinical picture is complicated by significant comorbid mood, anxiety, or PTSD symptoms that make attribution unclear.
Does PCS monitoring data support billing beyond a standard office visit?
Between-visit symptom and cognitive monitoring can support Remote Therapeutic Monitoring and neurocognitive testing billing codes when properly documented; see RTM 98978 and CPT 96132 for code-specific requirements, and note that coverage and documentation rules vary by payer.
Is PCS the same in pediatric and adult patients?
No — recovery timelines, symptom presentation, and appropriate return-to-learn/return-to-play protocols differ between pediatric and adult populations; see Pediatric Versus Adult Concussion Protocols.

See it on your patients

One field. 30 minutes. Live demo with a clinician.

Start with your emailCall (914) 705-6830 →